Crane vs DaVita Which Is More Lucrative?

Crane Co. and DaVita Inc. are two prominent companies in the healthcare industry, each with its own unique strengths and weaknesses. Crane Co. is a diversified manufacturer of industrial products, while DaVita is a leading provider of kidney dialysis services. Both companies have seen fluctuations in their stock prices in recent years, with Crane Co. benefiting from strong global demand for its products and DaVita facing challenges in the healthcare sector. Analyzing the performance of these stocks can provide valuable insights for investors looking to make informed decisions in the market.

Crane or DaVita?

When comparing Crane and DaVita, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Crane and DaVita.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Crane has a dividend yield of 0.46%, while DaVita has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Crane reports a 5-year dividend growth of -6.32% year and a payout ratio of 17.26%. On the other hand, DaVita reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Crane P/E ratio at 37.72 and DaVita's P/E ratio at 16.22. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Crane P/B ratio is 6.30 while DaVita's P/B ratio is 34.71.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Crane has seen a 5-year revenue growth of -0.34%, while DaVita's is 1.00%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Crane's ROE at 18.11% and DaVita's ROE at 110.29%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $172.74 for Crane and $155.26 for DaVita. Over the past year, Crane's prices ranged from $102.80 to $180.87, with a yearly change of 75.94%. DaVita's prices fluctuated between $94.61 and $168.50, with a yearly change of 78.10%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.